Secondary amyloidosis in a patient with long duration Crohn's disease treated with infliximab.

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Systemic AA amyloidosis is a serious complication of many chronic inflammatory disorders. Its association with Crohn's disease implies that the inflammatory burden is high enough for amyloid fibrils to form deposits in tissues. A case is presented in which this complication occurred while the patient was clinically well, with biological and endoscopic markers showing an inactive or mildly active disease under anti-tumor necrosis factor alpha therapy.
Original languageUnknown
Pages (from-to)15-7
JournalBiodrugs
Volume24 Suppl 1
Issue numberNA
DOIs
Publication statusPublished - 1 Jan 2010

Cite this